Literature DB >> 27742545

Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection.

Salvador Iborra1, María Martínez-López2, Francisco J Cueto3, Ruth Conde-Garrosa2, Carlos Del Fresno2, Helena M Izquierdo2, Clare L Abram4, Daiki Mori5, Yolanda Campos-Martín6, Rosa María Reguera7, Benjamin Kemp8, Sho Yamasaki5, Matthew J Robinson8, Manuel Soto9, Clifford A Lowell4, David Sancho10.   

Abstract

C-type lectin receptors sense a diversity of endogenous and exogenous ligands that may trigger differential responses. Here, we have found that human and mouse Mincle bind to a ligand released by Leishmania, a eukaryote parasite that evades an effective immune response. Mincle-deficient mice had milder dermal pathology and a tenth of the parasite burden compared to wild-type mice after Leishmania major intradermal ear infection. Mincle deficiency enhanced adaptive immunity against the parasite, correlating with increased activation, migration, and priming by Mincle-deficient dendritic cells (DCs). Leishmania triggered a Mincle-dependent inhibitory axis characterized by SHP1 coupling to the FcRγ chain. Selective loss of SHP1 in CD11c+ cells phenocopies enhanced adaptive immunity to Leishmania. In conclusion, Leishmania shifts Mincle to an inhibitory ITAM (ITAMi) configuration that impairs DC activation. Thus, ITAMi can be exploited for immune evasion by a pathogen and may represent a paradigm for ITAM-coupled receptors sensing self and non-self.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27742545      PMCID: PMC5074365          DOI: 10.1016/j.immuni.2016.09.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  46 in total

1.  Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

Authors:  J Karttunen; S Sanderson; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM.

Authors:  Benoit Pasquier; Pierre Launay; Yutaka Kanamaru; Ivan C Moura; Séverine Pfirsch; Claude Ruffié; Dominique Hénin; Marc Benhamou; Marina Pretolani; Ulrich Blank; Renato C Monteiro
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

Review 3.  Inhibitory ITAMs as novel regulators of immunity.

Authors:  Ulrich Blank; Pierre Launay; Marc Benhamou; Renato C Monteiro
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

4.  Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.

Authors:  Supriya Srivastav; Susanta Kar; Ajit G Chande; Robin Mukhopadhyaya; Pijush K Das
Journal:  J Immunol       Date:  2012-06-08       Impact factor: 5.422

5.  C-Type Lectin Receptor MCL Facilitates Mincle Expression and Signaling through Complex Formation.

Authors:  Yasunobu Miyake; Oh-hora Masatsugu; Sho Yamasaki
Journal:  J Immunol       Date:  2015-04-17       Impact factor: 5.422

6.  Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate.

Authors:  Hanne Schoenen; Barbara Bodendorfer; Kelly Hitchens; Silvia Manzanero; Kerstin Werninghaus; Falk Nimmerjahn; Else Marie Agger; Steffen Stenger; Peter Andersen; Jürgen Ruland; Gordon D Brown; Christine Wells; Roland Lang
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

7.  Identification of distinct ligands for the C-type lectin receptors Mincle and Dectin-2 in the pathogenic fungus Malassezia.

Authors:  Tetsuaki Ishikawa; Fumie Itoh; Sayumi Yoshida; Shinobu Saijo; Tetsuhiro Matsuzawa; Tohru Gonoi; Takashi Saito; Yoshio Okawa; Nobuyuki Shibata; Tomofumi Miyamoto; Sho Yamasaki
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

8.  The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans.

Authors:  Christine A Wells; Judith A Salvage-Jones; Xin Li; Kelly Hitchens; Suzanne Butcher; Rachael Z Murray; Anthony G Beckhouse; Yu-Lan-Sandra Lo; Silvia Manzanero; Christian Cobbold; Kate Schroder; Bo Ma; Sally Orr; Lauren Stewart; Daniel Lebus; Peter Sobieszczuk; David A Hume; Jennifer Stow; Helen Blanchard; Robert B Ashman
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Fungal engagement of the C-type lectin mincle suppresses dectin-1-induced antifungal immunity.

Authors:  Brigitte A Wevers; Tanja M Kaptein; Esther M Zijlstra-Willems; Bart Theelen; Teun Boekhout; Teunis B H Geijtenbeek; Sonja I Gringhuis
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

10.  Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.

Authors:  Florian Woelbing; Susanna Lopez Kostka; Katharina Moelle; Yasmine Belkaid; Cord Sunderkoetter; Sjef Verbeek; Ari Waisman; Axel P Nigg; Juergen Knop; Mark C Udey; Esther von Stebut
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

View more
  35 in total

Review 1.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

Review 2.  Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm.

Authors:  Aakanksha Jain; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

3.  Mincle-binding DNA aptamer demonstrates therapeutic potential in a model of inflammatory bowel disease.

Authors:  Matthew Stephens; Keith Keane; Simon Roizes; Shan Liao; Pierre-Yves von der Weid
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-02       Impact factor: 10.183

4.  M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1.

Authors:  Murugesan V S Rajaram; Eusondia Arnett; Abul K Azad; Evelyn Guirado; Bin Ni; Abigail D Gerberick; Li-Zhen He; Tibor Keler; Lawrence J Thomas; William P Lafuse; Larry S Schlesinger
Journal:  Cell Rep       Date:  2017-10-03       Impact factor: 9.423

5.  DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.

Authors:  Francisco J Cueto; Carlos Del Fresno; Paola Brandi; Alexis J Combes; Elena Hernández-García; Alfonso R Sánchez-Paulete; Michel Enamorado; Christian P Bromley; Manuel J Gomez; Ruth Conde-Garrosa; Santos Mañes; Santiago Zelenay; Ignacio Melero; Salvador Iborra; Matthew F Krummel; David Sancho
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

Review 6.  The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.

Authors:  Anand Kumar Gupta; Sonali Das; Mohd Kamran; Sarfaraz Ahmad Ejazi; Nahid Ali
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 7.  Function of Macrophage and Parasite Phosphatases in Leishmaniasis.

Authors:  Didier Soulat; Christian Bogdan
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

Review 8.  How to master the host immune system? Leishmania parasites have the solutions!

Authors:  Matteo Rossi; Nicolas Fasel
Journal:  Int Immunol       Date:  2018-03-10       Impact factor: 4.823

9.  Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation.

Authors:  Sanae Ben Mkaddem; Amaya Murua; Héloise Flament; Dimitri Titeca-Beauport; Carine Bounaix; Luca Danelli; Pierre Launay; Marc Benhamou; Ulrich Blank; Eric Daugas; Nicolas Charles; Renato C Monteiro
Journal:  Nat Commun       Date:  2017-08-15       Impact factor: 14.919

10.  The C-Type Lectin Mincle: Clues for a Role in Crohn's Disease Adjuvant Reaction.

Authors:  Anje A Te Velde
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.